Загрузка...
Fenofibrate Therapy in Carnitine Palmitoyl Transferase Type 2 Deficiency
Bezafibrate therapy has been shown to improve beta-oxidation of fatty acids and to reduce episodes of rhabdomyolysis in patients with carnitine palmitoyltransferase type-2 (CPT2) deficiency. We report the efficacy of fenofibrate in a patient with CPT2 deficiency, in whom beta-oxidation was improved...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi Publishing Corporation
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3521633/ https://ncbi.nlm.nih.gov/pubmed/23326270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/163173 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|